









Markets
/
Stocks
/
nasdaq-pypd
/

PolyPid Ltd

PYPD

View Detailed Chart

3.410USD

+0.040+1.19%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

34.75MMarket Cap

LossP/E TTM



PolyPid Ltd

3.410

+0.040+1.19%

Overview Company Financials

Financials

Intraday

30m

Today

+1.19%

5 Days

-7.34%

1 Month

-2.57%

6 Months

+15.20%

Year to Date

+12.17%

1 Year

-3.40%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

BUY

Current Rating

12.750

Target Price

273.90%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

173

Total

Median

Average

Company name

Ratings

Analysts

PolyPid Ltd

PYPD

Biogen Inc

BIIB

Alnylam Pharmaceuticals Inc

ALNY

Vertex Pharmaceuticals Inc

VRTX

Amgen Inc

AMGN

Gilead Sciences Inc

GILD

...

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Neutral

Sell(5)

Neutral(2)

Buy(4)

Indicators

Sell(2)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

-0.099

Neutral

RSI(14)

44.721

Neutral

STOCH(KDJ)(9,3,3)

14.679

Oversold

ATR(14)

0.177

Low Volatility

CCI(14)

-115.025

Sell

Williams %R

81.967

Oversold

TRIX(12,20)

0.181

Sell

StochRSI(14)

21.267

Buy

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

3.470

Sell

MA10

3.604

Sell

MA20

3.567

Sell

MA50

3.381

Buy

MA100

3.064

Buy

MA200

3.106

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Polypid Ltd is a biopharmaceutical company at the clinical stage, based in Israel . The company focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

Ticker SymbolPYPD

CompanyPolyPid Ltd

CEOMs. Dikla Czaczkes Akselbrad

Websitehttps://www.polypid.com